MitoGenetics is a biomedical technology company producing intellectual property and proprietary compounds designed to improve the health of humans, animals and plants.
The Primary focus of the technology is on the regulation of a cell, the basic unit of life, and the cell's organelles called the mitochondria through the use of a novel group of natural chemical products.
Our research projects has led to major breakthroughs in therapeutic strategies in human disease disorders that have been functionally linked to cellular mitochondrial dysfunction.